Protein ETHE1, mitochondrial, also known as "ethylmalonic encephalopathy 1 protein" and "per sulfide dioxygenase", is a protein that in humans is encoded by the ETHE1 gene located on chromosome 19.[5]

ETHE1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesETHE1, HSCO, YF13H12, persulfide dioxygenase, ETHE1 persulfide dioxygenase
External IDsOMIM: 608451 MGI: 1913321 HomoloGene: 8622 GeneCards: ETHE1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_014297
NM_001320867
NM_001320868
NM_001320869

NM_023154
NM_001364014

RefSeq (protein)

NP_001307796
NP_001307797
NP_001307798
NP_055112

NP_075643
NP_001350943

Location (UCSC)Chr 19: 43.51 – 43.53 MbChr 7: 24.29 – 24.31 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Structure edit

The human ETHE1 gene consists of 7 exons and encodes for a protein that is approximately 27 kDa in size.

Function edit

This gene encodes a protein that is expressed mainly in the gastrointestinal tract, but also in several other tissues such as the liver and the thyroid.[5]

The ETHE1 protein is thought to localize primarily to the mitochondrial matrix[6][7] and functions as a sulfur dioxygenase. Sulfur deoxygenates are proteins that function in sulfur metabolism. The ETHE1 protein is thought to catalyze the following reaction:

sulfur + O2 + H2O   sulfite + 2 H+ (overall reaction)
(1a) glutathione + sulfur   S-sulfanylglutathione (glutathione persulfide, spontaneous reaction)
(1b) S-sulfanylglutathione + O2 + H2O   glutathione + sulfite + 2 H+[6]

and requires iron[8] and possibly glutathione[8] as cofactors. The physiological substrate of ETHE1 is thought to be glutathione persulfide,[8] an intermediate metabolite involved in hydrogen sulfide degradation.


Clinical significance edit

Mutations in ETHE1 gene are thought to cause ethylmalonic encephalopathy,[7][9] a rare inborn error of metabolism. Patients carrying ETHE1 mutations have been found to exhibit lower activity of ETHE1 and affinity for the ETHE1 substrate.[8] Mouse models of Ethe1 genetic ablation likewise exhibited reduced sulfide dioxygenase catabolism and cranial features of ethylmalonic encephalopathy.[6] Decrease in sulfide dioxygenase activity results in abnormal catabolism of hydrogen sulfide, a gas-phase signaling molecule in the central nervous system,[8] whose accumulation is thought to inhibit cytochrome c oxidase activity in the respiratory chain of the mitochondrion.[6] However, other metabolic pathways may also be involved that could exert a modulatory effect on hydrogen sulfide toxicity.[10]

Interactions edit

ETHE1 has been shown to interact with RELA.[11]

References edit

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000105755Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000064254Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: ETHE1 ethylmalonic encephalopathy 1".
  6. ^ a b c d Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M, Zeviani M (2009). "Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy". Nat. Med. 15 (2): 200–5. doi:10.1038/nm.1907. hdl:11577/3321438. PMID 19136963. S2CID 5970257.
  7. ^ a b Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E, Mandel H, Balestri P, Garcia-Silva MT, Vollmer B, Rinaldo P, Hahn SH, Leonard J, Rahman S, Dionisi-Vici C, Garavaglia B, Gasparini P, Zeviani M (2004). "Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein". Am. J. Hum. Genet. 74 (2): 239–52. doi:10.1086/381653. PMC 1181922. PMID 14732903.
  8. ^ a b c d e Kabil O, Banerjee R (2012). "Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism". J. Biol. Chem. 287 (53): 44561–7. doi:10.1074/jbc.M112.407411. PMC 3531769. PMID 23144459.
  9. ^ "Encephalopathy, Ethylmalonic". Johns Hopkins University. Retrieved 2012-05-12.
  10. ^ Barth M, Ottolenghi C, Hubert L, Chrétien D, Serre V, Gobin S, Romano S, Vassault A, Sefiani A, Ricquier D, Boddaert N, Brivet M, de Keyzer Y, Munnich A, Duran M, Rabier D, Valayannopoulos V, de Lonlay P (2010). "Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy". J. Inherit. Metab. Dis. 33 (Suppl 3): S443–53. doi:10.1007/s10545-010-9227-y. PMID 20978941. S2CID 29056515.
  11. ^ Higashitsuji H, Higashitsuji H, Nagao T, Nonoguchi K, Fujii S, Itoh K, Fujita J (Oct 2002). "A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis". Cancer Cell. 2 (4): 335–46. doi:10.1016/S1535-6108(02)00152-6. hdl:2433/148468. PMID 12398897.

Further reading edit